Pathfinder Cell Therapy Stock Net Income
| PFND Stock | USD 0.0001 0.00 0.00% |
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pathfinder Cell, as well as the relationship between them.
Pathfinder Cell's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pathfinder Cell's valuation are provided below:Pathfinder Cell Therapy does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Pathfinder |
Pathfinder Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pathfinder Cell's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pathfinder Cell.
| 11/28/2025 |
| 02/26/2026 |
If you would invest 0.00 in Pathfinder Cell on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding Pathfinder Cell Therapy or generate 0.0% return on investment in Pathfinder Cell over 90 days. Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-deriv... More
Pathfinder Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pathfinder Cell's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pathfinder Cell Therapy upside and downside potential and time the market with a certain degree of confidence.
Pathfinder Cell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pathfinder Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pathfinder Cell's standard deviation. In reality, there are many statistical measures that can use Pathfinder Cell historical prices to predict the future Pathfinder Cell's volatility.Pathfinder Cell Therapy Backtested Returns
We have found three technical indicators for Pathfinder Cell Therapy, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pathfinder Cell are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Pathfinder Cell Therapy has perfect predictability. Overlapping area represents the amount of predictability between Pathfinder Cell time series from 28th of November 2025 to 12th of January 2026 and 12th of January 2026 to 26th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pathfinder Cell Therapy price movement. The serial correlation of 1.0 indicates that 100.0% of current Pathfinder Cell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Pathfinder Cell Therapy reported net income of (1.39 Million). This is 100.41% lower than that of the Biotechnology sector and 101.99% lower than that of the Health Care industry. The net income for all United States stocks is 100.24% higher than that of the company.
Pathfinder Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pathfinder Cell's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Pathfinder Cell could also be used in its relative valuation, which is a method of valuing Pathfinder Cell by comparing valuation metrics of similar companies.Pathfinder Cell is currently under evaluation in net income category among its peers.
Pathfinder Fundamentals
| Return On Asset | -8.89 | |||
| Current Valuation | 7.41 M | |||
| Shares Outstanding | 667.16 M | |||
| EBITDA | (1.67 M) | |||
| Net Income | (1.39 M) | |||
| Cash And Equivalents | 4 K | |||
| Total Debt | 5.41 M | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (963 K) | |||
| Beta | 0.14 | |||
| Market Capitalization | 2 M | |||
| Total Asset | 106 K | |||
| Retained Earnings | (19.23 M) | |||
| Working Capital | (6.76 M) | |||
| Current Asset | 9 K | |||
| Current Liabilities | 6.77 M | |||
| Net Asset | 106 K |
About Pathfinder Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pathfinder Cell Therapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pathfinder Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pathfinder Cell Therapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pathfinder Pink Sheet
Pathfinder Cell financial ratios help investors to determine whether Pathfinder Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pathfinder with respect to the benefits of owning Pathfinder Cell security.